Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
I'm Ready to Subscribe
Special Offers
DNBi. Leverage D&B's credit assessment tools.

Oxford BioMedica plc · Oxford United Kingdom (London SETS: OXB)

Medawar Centre, Robert Robinson Avenue,
The Oxford Science Park
Phone: +44-1865-783-000
OxfordFax: +44-1865-783-001
OX4 4GA
United KingdomMap Map This Company
  • Company Profiles
  • Competitive Landscapes
  • Industry Reports

Buy Reports

For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now

Oxford BioMedica plc Rankings

Company Description

Oxford BioMedica has no reservations about launching attacks on disease. The biotechnology company uses gene therapy and immunotherapy to develop treatments for cancer, as well as neurodegenerative and ocular diseases. Its four ocular gene therapies are partnered with Sanofi; the company works with Pfizer on another targeted antibody therapy. The company has three lead products: TroVax, ProSavin, and RetinoStat (being developed with Sanofi). TroVax is in late-stage clinical trials for the treatment of prostate cancer. ProSavin is being tested to treat Parkinson's disease using the company's LentiVector platform. RetinoStat is in clinical trials to treat wet age-related macular degeneration.

 

To read the full description: Subscribe Now
left-headOxford BioMedica plc Reports
right-head

No subscription, no problem.

Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Shop Reports
Shop Reports

Financials

Company TypePublic - London SETS: OXB Headquarters
Fiscal Year-EndDecember
2010 Employees78
More Oxford BioMedica plc Financials

Executives

15 executives listed for Oxford BioMedica plc's Oxford, United Kingdom location.

ChairmanAlan KingsmanE-mail
Deputy ChairmanNick RodgersE-mail
CEO and DirectorJohn DawsonE-mail

More Oxford BioMedica plc Executives

Top Oxford BioMedica plc Competitors

Sponsored Links